Open an account

Lonza Group AG

LZAGF · SWISS

$761.21+$16.21 (+2.18%)TodayMarket closed ·
Prev close $745.00

About LZAGF

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt and currently employs 16,866 full-time employees. The company went IPO on 2002-04-03. The firm's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The firm divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.

Employees
16,866
Headquarters
Basel, Basel-Stadt
Listed
Apr 3, 2002
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
lonza.com

LZAGF key statistics

Market cap
41.16B
Price-earnings ratio
0.00
Dividend yield
0.91%
Average volume
201
Volume
404
Open price
$750.00
High today
$773.44
Low today
$728.50
52 Week high
$755.96
52 Week low
$565.14

Lonza Group AG (LZAGF) at a glance

As of Oct 20, 2026, Lonza Group AG (LZAGF) shares are priced at $761.21, giving the company a market cap of 41.16B, a price-to-earnings ratio of 0.00 and a dividend yield of 0.91%.

Today the stock has traded between $728.50 and $773.44. The current price is 4.5% above the day's low and 1.6% below its high.

Volume so far is 404 shares, above the average of 201 shares a day.

Over the past year Lonza Group AG has ranged from $565.14 to $755.96, and now sits 103% of the way up that range.

Lonza Group AG met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $8.61 per share against an estimate of $9.07.

LZAGF earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 16.1% on average.

  1. Q4 FY22: reported $7.43 per share against an estimate of $7.46
  2. Q2 FY23: reported $6.12 per share against an estimate of $7.13
  3. Q4 FY23: reported $6.27 per share against an estimate of $6.80
  4. Q2 FY24: reported $7.02 per share against an estimate of $5.22
  5. Q4 FY24: reported $7.99 per share against an estimate of $7.48
  6. Q2 FY25: reported $7.51 per share against an estimate of $7.00
  7. Q4 FY25: reported $7.52 per share against an estimate of $9.66
  8. Q2 FY26: reported $8.61 per share against an estimate of $9.07

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.